Etv6 Runx1 - Cancer Science

Relevant Publications

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.

Issue Release: 2024

CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

Issue Release: 2024

Long Noncoding RNA Expression in Acute Lymphoblastic Leukemia: A Systematic Review.

Issue Release: 2024

Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia.

Issue Release: 2024

Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.

Issue Release: 2024

IKZF1 alterations contribute to outcome disparities in Hispanic/Latino children with B-lymphoblastic leukemia.

Issue Release: 2024

[Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].

Issue Release: 2024

Outcome and Prognostic Factors of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory ETV6/RUNX1-Positive Acute Lymphoblastic Leukemia.

Issue Release: 2024

Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies.

Issue Release: 2024

Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis.

Issue Release: 2024

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Issue Release: 2024

Immunophenotypic and Cytogenetic Characteristics of Pediatric Acute Lymphoblastic Leukemia: A Burden Estimation Study from Eastern India.

Issue Release: 2024

Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia.

Issue Release: 2024

ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?

Issue Release: 2024

The significance of CD49f expression in pediatric B-cell acute lymphoblastic leukemia.

Issue Release: 2024

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children\'s Oncology Group study.

Issue Release: 2024

Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.

Issue Release: 2024

Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.

Issue Release: 2024

An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia.

Issue Release: 2024

ETV6::RUNX1-like Acute Lymphoblastic Leukemia.

Issue Release: 2024

How Are New Treatments Discovered?

How Do Analytical APIs Benefit Cancer Research?

How Does the Immune System Detect Cancer Cells?

How do Patients Access Cancer Treatment?

What role do support groups play in cancer care?

How is Painless Swelling Diagnosed?

How are Treatment Options Determined?

Why Is Data Integration Important?

How is the aocns® Examination Structured?

What are the Challenges in Data Monitoring?

Partnered Content Networks

Relevant Topics